SCHEMBL6495427

SCHEMBL6495427

COc1ccc(-c2cc3ccccc3[nH]2)cc1NC(=S)N[C@H](C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
GAA P10253 1/20 0.48
SMO Q99835 1/20 0.45
ALOX15 P16050 1/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
RCE1 Q9Y256 1/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504212 1.00 ALDH1A1 (0.48) ALDH1A1GAASMOALOX15MAPT
SCHEMBL6505067 0.89 ALDH1A1 (0.45) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL6495159 0.81 RAB9A (0.51) ALDH1A1SMOALOX15MAPTRAB9A
SCHEMBL6496744 0.79 KMT2A (0.51) ALDH1A1GAASMOALOX15MAPT
SCHEMBL6494681 0.78 SMO (0.54) ALDH1A1SMOALOX15MAPTRAB9A
SCHEMBL6505453 0.76 SMO (0.50) ALDH1A1GAASMOALOX15MAPT
SCHEMBL6495430 0.76 KMT2A (0.44) ALDH1A1GAASMOALOX15MAPT
SCHEMBL6503173 0.75 RAB9A (0.58) ALDH1A1SMOALOX15MAPTRAB9A
SCHEMBL31616467 0.75 LMNA (0.61) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL31616406 0.75 LMNA (0.61) ALDH1A1GAAKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858739-B2 Indole and benzimidazole 15-lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 2005-02-22 US disclosed
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors CONNOR DAVID THOMAS (US) 2004-02-26 US disclosed
EP-1294686-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2003-03-26 EP disclosed
WO-2001096299-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors ALOX15, ALOX5, ALOX12 ALDH1A1 470/4885GAA 3535/4885SMO 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.